Louise Gambone
Director Internal Medicine Cardiology
Research & Publications
Biography
News
Coauthors
Selected Publications
- Development and validation of an automated algorithm for end point adjudication for a large U.S. national registryFriedman DJ, Pierre D, Wang Y, Gambone L, Koutras C, Segawa C, Farb A, Vemulapalli S, Varosy PD, Masoudi FA, Lansky A, Curtis JP, Freeman JV. Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry. American Heart Journal 2022, 254: 102-111. PMID: 36007567, DOI: 10.1016/j.ahj.2022.08.006.
- TCT-432 FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final ResultsBouras G, Abizaid A, Lutz M, Carrie D, Weber-Albers J, Dudek D, Gambone L, Anderson J, Lansky A. TCT-432 FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results. Journal Of The American College Of Cardiology 2018, 72: b174. DOI: 10.1016/j.jacc.2018.08.1597.
- Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.Baumbach A, Mullen M, Brickman AM, Aggarwal SK, Pietras CG, Forrest JK, Hildick-Smith D, Meller SM, Gambone L, den Heijer P, Margolis P, Voros S, Lansky AJ. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study. EuroIntervention 2015, 11: 75-84. PMID: 25868876, DOI: 10.4244/eijy15m04_01.
- DE NOVO CORONARY LESIONS TREATED WITH THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS: 12-MONTH ANGIOGRAPHIC RESULTS FROM THE PROSPECTIVE RANDOMIZED MULTICENTER BIOFREEDOM CLINICAL TRIALCosta R, Abizaid A, Mehran R, Magalhaes M, Gambone L, Parise H, Silva E, Schuler G, Hauptmann K, Schofer J, Grube E. DE NOVO CORONARY LESIONS TREATED WITH THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS: 12-MONTH ANGIOGRAPHIC RESULTS FROM THE PROSPECTIVE RANDOMIZED MULTICENTER BIOFREEDOM CLINICAL TRIAL. Journal Of The American College Of Cardiology 2011, 57: e1645. DOI: 10.1016/s0735-1097(11)61645-8.
- PRELIMINARY ANGIOGRAPHIC RESULTS OF THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS FOR THE TREATMENT OF CORONARY ARTERY LESIONS - FOUR-MONTH ANGIOGRAPHIC FOLLOW-UP OF THE PROSPECTIVE, RANDOMIZED, MULTICENTER BIOFREEDOM TRIALCosta R, Abizaid A, Mehran R, Lansky A, Magalhaes M, Gambone L, Parise H, Schuler G, Hauptmann K, Schofer J, Grube E. PRELIMINARY ANGIOGRAPHIC RESULTS OF THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS FOR THE TREATMENT OF CORONARY ARTERY LESIONS - FOUR-MONTH ANGIOGRAPHIC FOLLOW-UP OF THE PROSPECTIVE, RANDOMIZED, MULTICENTER BIOFREEDOM TRIAL. Journal Of The American College Of Cardiology 2010, 55: a192.e1801. DOI: 10.1016/s0735-1097(10)61802-5.
- IMPACT OF ANEMIA IN MEN AND WOMEN WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: THE HORIZONS-AMI TRIALTsujita K, Nikolsky E, Lansky A, Gambone L, Vandertie L, Caixeta A, Dangas G, Brodie B, Dudek D, Möckel M, Ochala A, Mehran R, Stone G. IMPACT OF ANEMIA IN MEN AND WOMEN WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: THE HORIZONS-AMI TRIAL. Journal Of The American College Of Cardiology 2010, 55: a138.e1299. DOI: 10.1016/s0735-1097(10)61300-9.
- IMPACT OF INTRAVENOUS HEPARIN ADMINISTERED PRIOR TO PRIMARY PERCUTANEOUS CORONARY INTERVENTION: ANALYSIS FROM THE HORIZONS-AMI TRIALNikolsky E, Mehran R, Dangas G, Lansky A, Rabbani L, Guagliumi G, Kornowski R, Hartmann F, Fahy M, Witzenbichler B, Peruga J, Gambone L, Parise H, Stone G. IMPACT OF INTRAVENOUS HEPARIN ADMINISTERED PRIOR TO PRIMARY PERCUTANEOUS CORONARY INTERVENTION: ANALYSIS FROM THE HORIZONS-AMI TRIAL. Journal Of The American College Of Cardiology 2010, 55: a185.e1729. DOI: 10.1016/s0735-1097(10)61730-5.
- Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialMehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Wong SC, Nikolsky E, Gambone L, Vandertie L, Parise H, Dangas GD, Stone GW, Investigators F. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. The Lancet 2009, 374: 1149-1159. PMID: 19717185, DOI: 10.1016/s0140-6736(09)61484-7.
- Cobalt chromium stent with antiproliferative for restenosis trial in India (COSTAR I).Kaul U, Gupta RK, Mathur A, Dani S, Sapra R, Nayak PR, Lansky A, Cristea E, Carlier S, Gambone L, Litvack F. Cobalt chromium stent with antiproliferative for restenosis trial in India (COSTAR I). Indian Heart Journal 2007, 59: 165-72. PMID: 19122251.
- The Effect of Variable Dose and Release Kinetics on Neointimal Hyperplasia Using a Novel Paclitaxel-Eluting Stent Platform The Paclitaxel In-Stent Controlled Elution Study (PISCES)Serruys P, Sianos G, Abizaid A, Aoki J, Heijer P, Bonnier H, Smits P, McClean D, Verheye S, Belardi J, Condado J, Pieper M, Gambone L, Bressers M, Symons J, Sousa E, Litvack F. The Effect of Variable Dose and Release Kinetics on Neointimal Hyperplasia Using a Novel Paclitaxel-Eluting Stent Platform The Paclitaxel In-Stent Controlled Elution Study (PISCES). Journal Of The American College Of Cardiology 2005, 46: 253-260. PMID: 16022951, DOI: 10.1016/j.jacc.2005.03.069.